Tofacitinib for the treatment of ulcerative colitis: an update on the analysis of malignancy rates from the UC clinical programme

Gary R. Lichtenstein  1     Matthew A. Ciorba  2     Gerhard Rogler  3     Daniel Quirk  4     Andrew J. Thorpe  4     Ronald D. Pedersen  4     Nervin Lawendy  5     Gary Chan     Julian Panés    
1 Perelman School of Medicine at the University of Pennsylvania,Philadelphia,United States
2 Washington University in Saint Louis,Saint Louis,United States
3 University of Zürich,Zürich,Switzerland
4 Pfizer Inc,Collegeville, PA,United States
5 Pfizer Inc,

IBD I (Posters)

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing